Compare Quant Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹1000 | ₹500 |
Expense Ratio | 2.42 | 1.93 |
NAV | ₹14.80 | ₹419.06 |
Fund Started | 27 Jun 2023 | 04 Jun 1999 |
Fund Size | ₹378.53 Cr | ₹4130.76 Cr |
Exit Load | Exit load of 1%, if redeemed within 15 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹1000
₹500
Expense Ratio
2.42
1.93
NAV
₹14.80
₹419.06
Fund Started
27 Jun 2023
04 Jun 1999
Fund Size
₹378.53 Cr
₹4130.76 Cr
Exit Load
Exit load of 1%, if redeemed within 15 days.
Exit load of 0.50% if redeemed within 15 days
1 Year | -4.69% | -1.76% |
3 Year | - | 23.67% |
5 Year | - | 16.49% |
1 Year
-4.69%
-1.76%
3 Year
-
23.67%
5 Year
-
16.49%
Equity | 95.72% | 95.82% |
Cash | -3.34% | 4.11% |
Equity
95.72%
95.82%
Cash
-3.34%
4.11%
Top 10 Holdings |
|
|
Top 10 Holdings
Cipla Ltd. | 9.77% |
SMS Pharmaceuticals Ltd. | 9.66% |
Sequent Scientific Ltd. | 8.72% |
Aster DM Healthcare Ltd. | 7.85% |
Zydus Wellness Ltd. | 7.30% |
Aurobindo Pharma Ltd. | 7.04% |
Pfizer Ltd. | 6.30% |
Alivus Life Sciences Ltd | 5.85% |
Adani Enterprises Ltd. | 5.72% |
Anthem Biosciences Ltd. | 5.59% |
Sun Pharmaceutical Industries Ltd. | 11.97% |
Divi's Laboratories Ltd. | 6.90% |
Max Healthcare Institute Ltd. | 5.63% |
Cipla Ltd. | 4.45% |
Lupin Ltd. | 4.23% |
Lonza Group Ag | 4.01% |
Acutaas Chemicals Ltd. | 4.00% |
Torrent Pharmaceuticals Ltd. | 3.60% |
Laurus Labs Ltd. | 3.50% |
Fortis Healthcare Ltd. | 3.34% |
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 27 Jun 2023 | 04 Jun 1999 |
Description
The scheme seeks to long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
27 Jun 2023
04 Jun 1999